{"entity":{"type":"insider","cik":"0001625657","url":"/insider/0001625657","json_url":"/insider/0001625657.json","name":"New Leaf Venture Management III, L.L.C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":6,"first":"2017-10-02","last":"2023-10-27","span_basis":"filed_date"},"name_variants":[{"name":"New Leaf Venture Management III, L.L.C.","source":"filing","n_filings":6,"first_seen":"2017-10-02","last_seen":"2023-10-27"}],"transactions":[{"id":8694694,"accession":"0000899243-23-020044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-020044","line_url":"/filing/0000899243-23-020044#line-2","is_derivative":false,"issuer_cik":"0001340806","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001340806","owner_cik":null,"owner_name":"New Leaf Venture Management III, L.L.C.; New Leaf Venture Associates III, L.P.; New Leaf Biopharma Opportunities II, L.P.; New Leaf BPO Management II, L.L.C; New Leaf BPO Associates II, L.P.; Lathi Vijay K; New Leaf Ventures III, L.P.","owner_display_name":"New Leaf Venture Management III, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1372000.0,"shares_display":"1,372,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":1463386.0,"shares_owned_after_display":"1,463,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-25","filed_date":"2023-10-27","scope":"insider"},{"id":8694690,"accession":"0000899243-23-020044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-020044","line_url":"/filing/0000899243-23-020044#line-1","is_derivative":false,"issuer_cik":"0001340806","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001340806","owner_cik":null,"owner_name":"New Leaf Venture Management III, L.L.C.; New Leaf Venture Associates III, L.P.; New Leaf Biopharma Opportunities II, L.P.; New Leaf BPO Management II, L.L.C; New Leaf BPO Associates II, L.P.; Lathi Vijay K; New Leaf Ventures III, L.P.","owner_display_name":"New Leaf Venture Management III, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":171500.0,"shares_display":"171,500","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":395783.0,"shares_owned_after_display":"395,783","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-25","filed_date":"2023-10-27","scope":"insider"},{"id":4306145,"accession":"0000899243-21-032748","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-032748","line_url":"/filing/0000899243-21-032748#line-1","is_derivative":false,"issuer_cik":"0001625653","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001625653","owner_cik":null,"owner_name":"New Leaf Venture Associates III, L.P.; New Leaf Venture Management III, L.L.C.; New Leaf Ventures III, L.P.; New Leaf BPO Associates II, L.P.; New Leaf BPO Management II, L.L.C; New Leaf Biopharma Opportunities II, L.P.","owner_display_name":"New Leaf Venture Associates III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":235294.0,"shares_display":"235,294","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":3999998.0,"total_display":"3,999,998.00","total_whole":"3,999,998","shares_owned_after":913860.0,"shares_owned_after_display":"913,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-08-12","scope":"insider"},{"id":8024556,"accession":"0000899243-19-022047","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-19-022047","line_url":"/filing/0000899243-19-022047","is_derivative":false,"issuer_cik":"0001625653","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001625653","owner_cik":null,"owner_name":"New Leaf Venture Associates III, L.P.; New Leaf BPO Associates I, L.P.; New Leaf Venture Management III, L.L.C.; New Leaf Ventures III, L.P.; New Leaf Biopharma Opportunities I, L.P.","owner_display_name":"New Leaf Venture Associates III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":36.672335405,"price_display":"36.67","price_state":"stated","total_value":7334467.081,"total_display":"7,334,467.08","total_whole":"7,334,467","shares_owned_after":1991884.0,"shares_owned_after_display":"1,991,884","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-19","scope":"insider","n_lines":4},{"id":8024548,"accession":"0000899243-19-022047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-022047","line_url":"/filing/0000899243-19-022047","is_derivative":false,"issuer_cik":"0001625653","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001625653","owner_cik":null,"owner_name":"New Leaf Venture Associates III, L.P.; New Leaf BPO Associates I, L.P.; New Leaf Venture Management III, L.L.C.; New Leaf Ventures III, L.P.; New Leaf Biopharma Opportunities I, L.P.","owner_display_name":"New Leaf Venture Associates III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":36.0911,"price_display":"36.09","price_state":"stated","total_value":5413665.0,"total_display":"5,413,665.00","total_whole":"5,413,665","shares_owned_after":2067858.0,"shares_owned_after_display":"2,067,858","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-19","scope":"insider","n_lines":2},{"id":8098272,"accession":"0001209191-19-010317","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-010317","line_url":"/filing/0001209191-19-010317","is_derivative":false,"issuer_cik":"0001625653","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001625653","owner_cik":null,"owner_name":"New Leaf Ventures III, L.P.; New Leaf Biopharma Opportunities II, L.P.; New Leaf BPO Associates II, L.P.; New Leaf BPO Management II, L.L.C; New Leaf Venture Management III, L.L.C.; New Leaf Venture Associates III, L.P.","owner_display_name":"New Leaf Ventures III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":428571.0,"shares_display":"428,571","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":5999994.0,"total_display":"5,999,994.00","total_whole":"5,999,994","shares_owned_after":2242839.0,"shares_owned_after_display":"2,242,839","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-12","filed_date":"2019-02-14","scope":"insider","n_lines":2},{"id":6288846,"accession":"0001104659-18-042317","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-18-042317","line_url":"/filing/0001104659-18-042317","is_derivative":false,"issuer_cik":"0001625653","issuer_name":"Aptinyx Inc.","issuer_ticker":"APTX","issuer_name_source":null,"issuer_url":"/issuer/0001625653","owner_cik":null,"owner_name":"New Leaf Venture Management III, L.L.C.; New Leaf BPO Associates I, L.P.; New Leaf Ventures III, L.P.; New Leaf Biopharma Opportunities I, L.P.; New Leaf Venture Associates III, L.P.","owner_display_name":"New Leaf Venture Management III, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":4000000.0,"total_display":"4,000,000.00","total_whole":"4,000,000","shares_owned_after":2921734.0,"shares_owned_after_display":"2,921,734","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-25","filed_date":"2018-06-26","scope":"insider","n_lines":2},{"id":4647020,"accession":"0000899243-17-023140","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-17-023140","line_url":"/filing/0000899243-17-023140#line-6","is_derivative":false,"issuer_cik":"0001625653","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001625653","owner_cik":null,"owner_name":"New Leaf Biopharma Opportunities I, L.P.; New Leaf Venture Management III, L.L.C.; New Leaf Ventures III, L.P.; New Leaf BPO Associates I, L.P.; New Leaf Venture Associates III, L.P.","owner_display_name":"New Leaf Biopharma Opportunities I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":375000.0,"shares_display":"375,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":6375000.0,"total_display":"6,375,000.00","total_whole":"6,375,000","shares_owned_after":2146308.0,"shares_owned_after_display":"2,146,308","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001708493","name":"Harpoon Therapeutics, Inc.","url":"/issuer/0001708493","role":"Ten percent owner","n_filings":3,"first_seen":"2019-02-14","last_seen":"2023-10-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001654151","name":"Deciphera Pharmaceuticals, Inc.","url":"/issuer/0001654151","role":"Ten percent owner","n_filings":2,"first_seen":"2017-10-02","last_seen":"2019-08-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001674365","name":"Aptinyx Inc.","url":"/issuer/0001674365","role":"Ten percent owner","n_filings":1,"first_seen":"2018-06-26","last_seen":"2018-06-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001625657","retrieved_at":"2026-08-22T13:21:16+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}